| pubmed-article:17006999 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17006999 | lifeskim:mentions | umls-concept:C0035525 | lld:lifeskim |
| pubmed-article:17006999 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:17006999 | lifeskim:mentions | umls-concept:C0796545 | lld:lifeskim |
| pubmed-article:17006999 | lifeskim:mentions | umls-concept:C0445550 | lld:lifeskim |
| pubmed-article:17006999 | pubmed:issue | 34 | lld:pubmed |
| pubmed-article:17006999 | pubmed:dateCreated | 2006-9-28 | lld:pubmed |
| pubmed-article:17006999 | pubmed:abstractText | To assess the efficacy of peginterferon alpha 2b at doses of 50 microg weekly and 80 microg weekly (based on body weight) plus ribavirin in HCV genotype 2 and genotype 3 chronic hepatitis C patients. | lld:pubmed |
| pubmed-article:17006999 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17006999 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17006999 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17006999 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17006999 | pubmed:issn | 1007-9327 | lld:pubmed |
| pubmed-article:17006999 | pubmed:author | pubmed-author:GuptaRajeshR | lld:pubmed |
| pubmed-article:17006999 | pubmed:author | pubmed-author:ReddyD... | lld:pubmed |
| pubmed-article:17006999 | pubmed:author | pubmed-author:BanerjeeRupaR | lld:pubmed |
| pubmed-article:17006999 | pubmed:author | pubmed-author:TandanManuM | lld:pubmed |
| pubmed-article:17006999 | pubmed:author | pubmed-author:LakhtakiaSand... | lld:pubmed |
| pubmed-article:17006999 | pubmed:author | pubmed-author:RamakrishnaC... | lld:pubmed |
| pubmed-article:17006999 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17006999 | pubmed:day | 14 | lld:pubmed |
| pubmed-article:17006999 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:17006999 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17006999 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17006999 | pubmed:pagination | 5554-6 | lld:pubmed |
| pubmed-article:17006999 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:meshHeading | pubmed-meshheading:17006999... | lld:pubmed |
| pubmed-article:17006999 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17006999 | pubmed:articleTitle | Efficacy of low dose peginterferon alpha-2b with ribavirin on chronic hepatitis C. | lld:pubmed |
| pubmed-article:17006999 | pubmed:affiliation | Asian Institute of Gastroenterology, Somajiguda 63661, Hyderabad, India. | lld:pubmed |
| pubmed-article:17006999 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17006999 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17006999 | lld:pubmed |
